MOTS-c Sourcing Vocabulary and Catalogue Query Orthography: A Research Review of Mitochondrial-Derived Peptide Identity, AMPK Signalling, Exercise-Mimetic Pharmacology and the Resolution of "mot c peptide", "moc c peptide" and "mod-c peptide" Labels

By the Peptide Insider Research Desk · October 19 2026 · Research reference only

Community search logs for mot c peptide, moc c peptide, mod-c peptide, most-c and mot s peptide consistently point to a single canonical compound: MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c). This 16-amino-acid mitochondrial-derived peptide (MDP), encoded by a short open reading frame within the MT-RNR1 gene of the mitochondrial genome, has attracted sustained interest since its initial characterisation as a metabolic regulator in 2015 [1]. The present review resolves the most frequent orthographic variants encountered in catalogue and forum queries, maps each to the canonical identifier (UniProt A0A0C5B5G6), and surveys the preclinical evidence base for MOTS-c pharmacology—all strictly for research reference and not for human or veterinary use.

Key Facts at a Glance

• MOTS-c is encoded by a short open reading frame within the mitochondrial 12S rRNA gene (MT-RNR1) and was first described as a metabolic regulator in 2015 [1].
• Its primary signalling mechanism involves inhibition of the folate–methionine cycle, accumulation of AICAR and subsequent activation of AMPK [1, 2].
• Under metabolic stress, MOTS-c translocates from the cytoplasm to the nucleus, where it regulates antioxidant-response-element (ARE) genes via NRF2 [2].
• Circulating MOTS-c levels increase acutely after exercise in humans, positioning it as a candidate exercise-mimetic mitokine [3, 4].
• Preclinical models (high-fat-diet mice, aged mice) show improved insulin sensitivity and reduced adiposity upon MOTS-c administration, but no large-scale human efficacy trials have been completed [1, 5].

Catalogue Query Orthography: Resolving Community Variants

The unusual abbreviation "MOTS-c"—where the terminal lowercase "c" denotes the type-c reading frame within 12S rRNA—generates a disproportionate number of misspellings in commercial search queries. The table below classifies the most common variants by error mechanism and maps each to the canonical identifier.

Gene Structure and Peptide Biogenesis

MOTS-c is produced from a short open reading frame (sORF) embedded within the MT-RNR1 gene, which occupies nucleotide positions 648–1 601 of the human mitochondrial genome [1, 6]. Historically, MT-RNR1 was annotated solely as the gene encoding the mitochondrial 12S ribosomal RNA subunit. Lee et al. (2015) demonstrated that this locus additionally harbours a translated sORF yielding the 16-residue peptide MRWQEMGYIFYPRKLR [1]. The sORF is highly conserved across mammalian species, suggesting functional constraint [1, 6].

MOTS-c belongs to the broader family of mitochondrial-derived peptides (MDPs), which also includes humanin (encoded by MT-RNR2) and the six small humanin-like open reading frame (SHLP/SHMOSe) peptides [6, 7]. Together, these MDPs constitute a retrograde signalling axis through which the mitochondrial genome communicates bioenergetic status to the nuclear transcription apparatus [2, 7].

Mechanism of Action: Folate Cycle → AICAR → AMPK

The best-characterised signalling cascade downstream of MOTS-c proceeds through inhibition of the folate–methionine one-carbon cycle [1, 2]. By interfering with de novo purine biosynthesis, MOTS-c causes intracellular accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an AMP-mimetic intermediate that allosterically activates AMP-activated protein kinase (AMPK) [1]. Crucially, this activation pathway is independent of the canonical AMP:ATP ratio mechanism, meaning MOTS-c can engage AMPK even in energy-replete cells [1, 2].

AMPK activation by MOTS-c drives several downstream metabolic programmes: enhanced skeletal-muscle glucose uptake via GLUT4 translocation, suppression of hepatic gluconeogenesis, and increased mitochondrial fatty-acid β-oxidation [1, 5]. In neuropathic-pain models, intrathecal MOTS-c administration enhanced AMPKα1/2 phosphorylation in the spinal cord, and the analgesic effect was abolished by dorsomorphin (an AMPK inhibitor), confirming pathway dependence [8].

Nuclear Translocation and ARE Gene Regulation

Kim et al. (2018) demonstrated that MOTS-c undergoes stress-dependent translocation from the cytoplasm to the nucleus, where it associates with chromatin and co-regulates antioxidant response element (ARE) genes via interaction with the transcription factor NRF2 [2]. This translocation requires prior AMPK activation, establishing a sequential signalling hierarchy: metabolic stress → AMPK → nuclear import → NRF2-dependent gene expression [2]. The nuclear-localisation capacity of MOTS-c provides a direct mechanism for mitochondrial-to-nuclear (retrograde) communication that is distinct from classical ROS-mediated signalling.

Preclinical Evidence Summary

Exercise-Mimetic Classification and Endogenous Regulation

The designation of MOTS-c as an "exercise mimetic" originates from two convergent observations. First, exogenous MOTS-c administration in sedentary and aged mice reproduced metabolic adaptations—improved insulin sensitivity, enhanced mitochondrial respiration, increased fatty-acid oxidation—typically associated with aerobic training [1, 3, 5]. Second, circulating MOTS-c levels rise acutely in response to exercise in healthy human subjects [4]. Ramanjaneya et al. (2019) reported that plasma MOTS-c concentrations increased significantly following a single bout of aerobic exercise, and that baseline circulating levels were lower in individuals with type 2 diabetes compared to age-matched controls [4].

Reynolds et al. (2021) demonstrated that MOTS-c and voluntary exercise interact synergistically: combined treatment in aged mice improved PGC-1α expression and insulin-sensitivity markers to a greater extent than either intervention alone [3]. Kumagai et al. (2026) further established that MOTS-c improves intrinsic mitochondrial bioenergetic efficiency in skeletal muscle through a PGC-1α/AMPK-dependent mechanism [5].

Emerging Research Axes (2026)

Recent publications have expanded the scope of MOTS-c investigation beyond metabolic homeostasis. Li et al. (2026) reported improved bioenergetic parameters in ageing-associated ovarian granulosa cells treated with MOTS-c, suggesting a potential role in reproductive-ageing research [9]. Wang et al. (2026) demonstrated attenuation of sepsis-induced cardiomyopathy in murine models via MOTS-c-mediated preservation of mitochondrial membrane potential [10]. Chen et al. (2026) engineered an R13A-MOTS-c variant delivered via the LAT1 transporter that attenuated radiation-induced lung injury through Nrf2 activation, highlighting structure–activity relationship studies within the MOTS-c scaffold [12]. Additionally, Cinar et al. (2026) reported reduced circulating MOTS-c in a Hashimoto's thyroiditis cohort, correlating with integrated autoimmune and metabolic dysfunction markers [11].

Frequently Asked Questions

What is mot c peptide?

The query "mot c peptide" is a hyphen-drop orthographic variant of MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c), a 16-amino-acid mitochondrial-derived peptide encoded by the MT-RNR1 gene. MOTS-c activates AMPK via AICAR accumulation and has been studied for its role in metabolic homeostasis in preclinical models [1]. The compound is available as research-grade lyophilised material; it is not approved for human or veterinary use.

What is moc c peptide or mod-c peptide?

"Moc c peptide" and "mod-c peptide" are phonetic transpositions of MOTS-c. Both resolve to the same canonical compound (UniProt A0A0C5B5G6, sequence MRWQEMGYIFYPRKLR, MW 2 174.6 Da). The misspellings arise from the unfamiliar "MOTS" abbreviation being transcribed as "moc" or "mod" in community forums [1, 2].

What does mot c peptide for sale mean in research catalogues?

Catalogue listings for "mot c peptide for sale," "motc peptide for sale" and "mot c peptide where to buy" refer to synthetic MOTS-c supplied as lyophilised research-grade material. Researchers should verify sequence identity (MRWQEMGYIFYPRKLR), HPLC purity (≥95 %), and electrospray-ionisation mass-spectrometry (ESI-MS) confirmation of the 2 174.6 Da molecular ion before use in any experimental protocol. This material is strictly for research use only [1].

Is most-c a real peptide?

"Most-c" is a vowel-insertion typographic variant of MOTS-c. The canonical name derives from Mitochondrial Open reading frame of the Twelve S rRNA type-c. The peptide is well-characterised in peer-reviewed literature since 2015 [1] and is indexed in UniProt under accession A0A0C5B5G6.

What is ms10 peptide?

The query "ms10 peptide" is ambiguous: it may represent a digit-substitution variant of MOTS-c or refer to an unrelated fragment designation. Researchers encountering this term should cross-reference with the canonical MOTS-c sequence (MRWQEMGYIFYPRKLR) and UniProt accession A0A0C5B5G6 to confirm compound identity before procurement [1, 6].

Where to Source MOTS-c for Research

Synthetic MOTS-c is available from research-grade peptide suppliers for laboratory investigation. Researchers should verify certificate-of-analysis documentation confirming HPLC purity ≥95 % and ESI-MS molecular-ion confirmation. The following suppliers maintain catalogues that include mitochondrial-derived peptides for research use: Short Chain Aminos (primary catalogue), BioPep, Catalyst Research and Apex Research Services. Inclusion in this list does not constitute endorsement; no vendor has been assessed or endorsed by this publication. Researchers bear sole responsibility for verifying supplier quality-assurance documentation.

Works Cited

1. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454. PMID 25738459
2. Kim SJ, Xiao J, Wan J, Cohen P, Yen K. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metab. 2018;28(3):516–524.e7. PMID 29983246
3. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c interacts synergistically with exercise intervention to regulate PGC-1α expression, attenuate insulin resistance and enhance glucose metabolism in mouse skeletal muscle. Biochim Biophys Acta Mol Basis Dis. 2021;1867(6):166126. PMID 33722744
4. Ramanjaneya M, Bettahi I, Jerobin J, et al. Mitochondrial-derived peptides are down regulated in diabetes subjects. Front Endocrinol (Lausanne). 2019;10:331. PMID 31214116
5. Kumagai H, Natsume T, Kim SJ, et al. MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner. Free Radic Biol Med. 2026. PMID 41520850
6. Kim SJ, Mehta HH, Wan J, et al. Mitochondrial peptides modulate mitochondrial function during cellular senescence. Aging (Albany NY). 2018;10(6):1239–1256. PMID 29886458
7. Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY). 2016;8(4):796–809. PMID 27070352
8. Zhang Y, Yang M, Zhou Q, et al. Mitochondrial-derived peptide MOTS-c ameliorates spared nerve injury-induced neuropathic pain in mice via AMPK/microglial pathway. ACS Chem Neurosci. 2023;14(13):2426–2436. PMID 37285113
9. Li X, et al. The mitochondrial-derived peptide MOTS-c improves bioenergetics in aging-associated granulosa cells. Reprod Fertil. 2026. PMID 42895211
10. Wang F, et al. MOTS-c in sepsis-induced cardiomyopathy: Mechanisms and translational potential. Eur J Pharmacol. 2026. PMID 42633878
11. Cinar N, et al. Reduced circulating MOTS-c levels in Hashimoto's thyroiditis reflect integrated autoimmune and metabolic dysfunction. J Clin Med. 2026. PMID 42278864
12. Chen X, et al. LAT1-mediated delivery of engineered R13A-MOTS-c attenuates radiation-induced lung injury via Nrf2 activation. Redox Biol. 2026. PMID 42142418
13. Mangalhara KC, Shadel GS. A mitochondrial-derived peptide exercises the nuclear option. Cell Metab. 2018;28(3):330–331. PMID 30184481
14. D'Souza RF, Woodhead JST, Hedges CP, et al. Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition. Aging (Albany NY). 2020;12(6):5244–5258. PMID 32182209
15. Xinqiang Y, Quan C, Yuanyuan J, Hanmei X. Protective effect of MOTS-c on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol. 2020;80:106174. PMID 31931370

This article is provided strictly for research reference. The compounds discussed are research-use-only materials and are not intended, labelled, or approved for human or veterinary use. No dosing guidance is provided or implied. Researchers must comply with all applicable institutional, local and national regulations governing the procurement and use of research peptides.